Ignite Creation Date:
2025-12-24 @ 10:40 PM
Ignite Modification Date:
2026-03-08 @ 5:55 AM
Study NCT ID:
NCT03034135
Status:
COMPLETED
Last Update Posted:
2021-09-13
First Post:
2017-01-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability and Efficacy of Disulfiram and Copper Gluconate in Recurrent Glioblastoma
Sponsor:
Cantex Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-09
Start Date Type:
ACTUAL
Primary Completion Date:
2018-07-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-07-10
Completion Date Type:
ACTUAL
First Submit Date:
2017-01-25
First Submit QC Date:
None
Study First Post Date:
2017-01-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-04-02
Results First Submit QC Date:
None
Results First Post Date:
2021-09-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2021-09-13
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-08-17
Last Update Post Date:
2021-09-13
Last Update Post Date Type:
ACTUAL